A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation

類似資料

• Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation
  著者:: Modi, Dipenkumar, 等
  出版事項: (2016)
• Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation
  著者:: Al-Kadhimi, Zaid, 等
  出版事項: (2012)
• Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma
  著者:: Modi, Dipenkumar, 等
  出版事項: (2019)
• R-BEAM versus Reduced Intensity Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Relapsed Refractory Diffuse Large B Cell Lymphoma
  著者:: Modi, Dipenkumar, 等
  出版事項: (2019)
• Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients
  著者:: Modi, Dipenkumar, 等
  出版事項: (2017)